Noninferior: By What Margin?
- PMID: 41085302
- PMCID: PMC12599384
- DOI: 10.1097/ALN.0000000000005737
Noninferior: By What Margin?
Conflict of interest statement
Dr. Janda declares research support from BioIntellisense, Inc. and Haisco-USA Pharmaceuticals, Inc. paid to the University of Michigan and unrelated to presented work. Dr. Colquhoun declares research support from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Chiesi USA and GE Healthcare paid to the University of Michigan unrelated to presented work. Dr. Colquhoun reports receiving an honorarium from Medscape, Inc.
Comment on
- Anesthesiology.
References
-
- Sekela ME, Snyder EL, Welsby IJ, Toyoda Y, Alsammak M, Sodha NR, Beaver TM, Pelletier JPR, Gorham JD, McNeil JA, Sniecinski RM, Pearl RG, Nuttall GA, Sarode R, Reece TB, Benjamin RJ. Transfusion Efficacy of Amustaline/Glutathione Pathogen-Reduced Red Blood Cells in Cardiac Surgery – A Randomized Phase III Clinical Trial. Anesthesiology. 2025. - PMC - PubMed
-
- Bai AD, Komorowski AS, Lo CKL, Tandon P, Li XX, Mokashi V, Cvetkovic A, Findlater A, Liang L, Tomlinson G, Loeb M, Mertz D; McMaster Infectious Diseases Fellow Research Group. Confidence interval of risk difference by different statistical methods and its impact on the study conclusion in antibiotic non-inferiority trials. Trials. 2021. Oct 16;22(1):708. - PMC - PubMed
-
- Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, Goldstein SL, Cerdá J, Chawla LS: Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol 2018; 14:607–25. - PubMed
-
- See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR, Toussaint ND, Bellomo R. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int. 2019. Jan;95(1):160–172. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
